Vir Biotechnology, Inc.於2016年4月7日根據特拉華州法律註冊成立。該公司是一家免疫學公司,專註於結合前沿技術來治療和預防嚴重傳染病和其他嚴重疾病,包括病毒相關疾病。該公司的目標是通過兩種基本方式實現這一目標——第一,通過開發強大的抗體療法,第二,通過基於T細胞的病毒載體平台在體內產生獨特的T細胞反應。
董事
名稱
職位
George Scangos
President, Chief Executive Officer and Director
Vicki Sato
Chairman of the Board of Director
Dipchand Nishar
Director
Klaus Frueh
Director
Kristina Burow
Director
Phillip Sharp
Director
Robert More
Director
Robert Perez
Director
Robert Taylor NELSEN
Director
Saira Ramasastry
Director
股東
名稱
職位
George Scangos
President, Chief Executive Officer and Director
Howard Horn
Chief Financial Officer and Secretary
Herbert Virgin
Executive Vice President, Research and Chief Scientific Officer